Status:
UNKNOWN
Vaccination for Children of H&O and Their Parents
Lead Sponsor:
Children's Cancer Group, China
Collaborating Sponsors:
Shanghai Pudong District Center for Disease Control and Prevention
Conditions:
Vaccination
Hematologic Malignancy
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The purpose of this study is to study on compliance, safety and effectivity of vaccination for children with hematologic malignancies or solid tumors and their parents.
Detailed Description
Children with hematologic malignancies or solid tumors are all facing with immune deficiency due to the disease, the chemotherapy, the hematopoietic stem cell transplantation or the splenectomy, which...
Eligibility Criteria
Inclusion
- Children patients(≤18 years) who accepted chemotherapy, hematopoietic stem cell transplantation or splenectomy since our study started.
- No history of hepatitis B and measles, do not suffer from other diseases that affect immune function and allergic diseases.
Exclusion
- Children patients who did not reach clinical remission after treatment, critically ill or eventually died.
- Patients who used monoclonal antibodies, especially anti-tumor necrosis factors.
- Intermittent or low-dose chemotherapy or other immunosuppressive drugs users.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03373656
Start Date
May 1 2017
End Date
September 1 2025
Last Update
July 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Children's Medical Center
Shanghai, Shanghai Municipality, China, 200127